Serum/glucocorticoid-regulated kinase 1 (SGK1)

Class

SGK1 inhibitor

SGK1 (serum/glucocorticoid-regulated kinase 1) is an intracellular enzyme that adds phosphate groups to other proteins, thereby altering their activity, stability, or location within the cell. It is induced by stress hormones such as glucocorticoids and by growth-factor signaling through the PI3-kinase pathway, and it helps set the pace of cellular processes ranging from ion transport across epithelial membranes to cell survival and immune cell differentiation. Because SGK1 activity rises in response to salt intake, hyperglycemia, and inflammatory or fibrotic stimuli, it has become of interest to dampen its output in disease states where its activity contributes to pathological tissue remodeling, sodium retention, or dysregulated immune responses. Kidney fibrosis, cardiac fibrosis, hypertension driven by excess renal sodium reabsorption, and autoimmune conditions in which SGK1 promotes pro-inflammatory T-cell subsets are among the contexts where inhibiting this kinase is being explored. Small-molecule inhibitors of SGK1, such as the compound noted here, are designed to occupy the kinase's catalytic site and block its ability to phosphorylate downstream targets, with the goal of interrupting these pathological processes while, ideally, sparing the kinase's more essential physiological roles.